Skip to main content

Day: August 26, 2025

OTC Markets Group Welcomes Amaero Limited to OTCQX

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Amaero Limited (ASX: 3DA; OTCQX: AMROF), a company specializing in the research, development, manufacture, and sale of refractory metals and specialty alloy powders, has qualified to trade on the OTCQX® Best Market. Amaero LTD. upgraded to OTCQX from the OTCQB® Venture Market. Amaero Limited begins trading today on OTCQX under the symbol “AMROF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate...

Continue reading

Sagimet Biosciences to Participate in Two Upcoming Investor Conferences

SAN MATEO, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences.Cantor Global Healthcare Conference in New York on September 3, 2025, with a fireside chat at 1:35 p.m. ET / 10:35 a.m. PT; and H.C. Wainwright 27th Annual Global Investment Conference in New York on September 9, 2025.A webcast of the Cantor fireside chat will be available in the Investors & Media section of Sagimet’s website at www.sagimet.com, with an archived replay available for 90 days following the live event. About Sagimet Biosciences  Sagimet is a clinical-stage biopharmaceutical company developing novel fatty...

Continue reading

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, announced today that the management team will participate in three upcoming investor conferences in September 2025 as follows:Cantor Healthcare Conference: fireside chat at 8:00 am ET on Thursday, September 4th and available to host investor meetings September 3rd and 4th 2025 Wells Fargo Healthcare Conference: available to host investor meetings on September 5th H.C. Wainwright 26th Annual Global Investor Conference: presentation at 10:00 am ET on Tuesday, September 9th and available to host investor meetings September 8th and 9thA webcast of the fireside...

Continue reading

Artivo Surfaces, Backed by Transom Capital, Completes Acquisition of Walker Zanger and Anthology Brands from Mosaic Companies

LIVONIA, Mich., Aug. 26, 2025 (GLOBE NEWSWIRE) — Artivo Surfaces (“Artivo”), the parent company of Virginia Tile and GalleherDuffy, backed by Transom Capital (“Transom”), today announced it has successfully completed its previously announced acquisition of the Walker Zanger and Anthology brands from Mosaic Companies. “With today’s closing, we officially welcome Walker Zanger and Anthology to the Artivo platform,” said Sunil Palakodati, CEO of Artivo Surfaces. “This milestone not only marks a significant expansion of Artivo’s portfolio of premier brands, but also builds on the momentum we established with the 2024 combination of Galleher, Virginia Tile, and the Tom Duffy Company. As we integrate these iconic brands and honor their design legacies and customer-first values, Artivo is firmly positioned as a national leader in flooring...

Continue reading

ECARX Announces Second Quarter 2025 Unaudited Financial Results

SHANGHAI, Aug. 26, 2025 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial results for the quarter ended June 30, 2025. “The strong momentum we built in 2024 and early 2025 continued in the second quarter,” said Ziyu Shen, ECARX Chairman and CEO. “Revenue was US$155.6 million, reflecting the impact of typical seasonal headwinds and the timing of certain contracts, while the disciplined execution of our lean operating strategy reduced operating expenses by 20% to US$57.2 million. With a robust pipeline of new projects expected to launch over the next two quarters, we remain firmly on track to hit EBITDA breakeven in each of the remaining quarters and full-year 2025, and deliver close to 20% revenue growth for the year. Shipments of...

Continue reading

Draganfly Uniquely Positioned to Support Canada’s New $2 Billion Military Commitment to Ukraine with Advanced Drone and Tactical Capabilities

Saskatoon, SK, Aug. 26, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading developer of drone solutions and systems, today provided insight into its unique positioning to support Canada’s newly announced $2 billion military aid package to Ukraine, which includes over $220 million dedicated to drone, counter-drone, and electronic warfare capabilities. As the world’s oldest dual-use drone manufacturer with 27 years of design, engineering, and development experience—and one of a handful of Canadian manufacturers with proven solutions, Draganfly is uniquely positioned to support this critical national and international mission. Strategic Alignment with Canada’s Commitment Announced this weekend during Prime Minister Mark Carney’s historic visit to Kyiv on...

Continue reading

The Save Mart Companies Honored for Transforming Workers’ Comp Program in Collaboration with CorVel

FORT WORTH, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) — CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, congratulates its partner, The Save Mart Companies, one of the West Coast’s largest regional, full-service grocery chains, for being named one of three recipients of the 2025 Workers’ Compensation Risk Management Award for Excellence, presented by PropertyCasualty360. The award was announced at this year’s Workers’ Compensation Institute (WCI) Conference in Orlando, Florida. The Save Mart Companies risk management team, led by Rosie Partida, Director of Risk Management, is recognized for its transformation of the company’s workers’ compensation program through strategic innovation, enhanced safety protocols, and employee-first policies. Under Partida’s leadership, the company transitioned...

Continue reading

Gilat Receives an Additional $25 Million Agreement to Advance Digital Inclusion in Peru

Additional digital inclusion project in the Cusco region to deliver connectivity to public institutions, expanding access to essential services PETAH TIKVA, Israel, Aug. 26, 2025 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that its Peruvian subsidiary, Gilat Perú, has signed an additional $25 million agreement with Pronatel (Programa Nacional de Telecomunicaciones), Peru’s national telecommunications program. This award is for the modernization of the Regional Broadband network in the Cusco region. The migration is planned over the next 12 months, with services to be delivered for a period of five years. The upgraded network will provide high-speed internet of 200 Mbps to nearly 208 public institutions,...

Continue reading

Kraig Biocraft Laboratories Accelerates Operations into Two Rearing Centers in One of Southeast Asia’s Premier Silk-Producing Regions

ANN ARBOR, Mich., Aug. 26, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, today announced that its two recently established rearing centers, located in the heart of one of Asia’s leading silk-producing regions, have now completely replaced the Company’s original Prodigy Textiles pilot facility as the center of production. Since opening the first of these two new rearing centers in early 2024, Kraig Labs has produced more recombinant spider silk than in all previous years of the Company’s operations combined. These modern rearing centers provide an optimized production environment, combining advanced biotechnology with the region’s unmatched sericulture expertise, favorable climate, and...

Continue reading

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

WALTHAM, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for autoimmune diseases, today announced management’s presentations at the following investor conferences in September:Citi’s 2025 Biopharma Back to School Conference on Tuesday, September 2, 2025, at 1:00 p.m. ET Cantor Global Healthcare Conference 2025 on Wednesday, September 3, 2025, at 8:35 a.m. ET Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025, at 7:45 a.m. ETLive webcasts and archived replays of the Company’s presentations can be accessed under “Events and Presentations” in the Investor & Media Relations section...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.